Clinical validation of MR‐generated synthetic CT by MRCAT for brain tumor radiotherapy

Tyrone Tsz Yeung Yip,Zhichun Li,Tian Li
DOI: https://doi.org/10.1002/acm2.14494
2024-12-15
Journal of Applied Clinical Medical Physics
Abstract:Objective MRI is an emerging modality in radiotherapy (RT). Accuracy synthetic CT is the prerequisite for implementing MR‐only RT planning. This study validated the commercial algorithm of MR for calculating attenuation (MRCAT) in terms of image quality and dosimetric agreement. Methods Brain tumor cases with 18 treated using intensity‐modulated radiotherapy (IMRT) or volumetric modulated arc therapy (VMAT), and 15 treated using stereotactic radiosurgery (SRS) were analyzed. Synthetic CTs were resampled referencing planning CT. Treatment plan calculated on planning CT was recalculated on resampled MRCAT. Image quality of selected metrics and dosimetric agreements were assessed by dose‐volume‐histogram and 3D gamma analysis. Results For IMRT/VMAT and SRS cases, mean error were 23.42 ± 1.05 and 28.39 ± 3.17 HU; mean absolute error were 38.03 ± 1.42 and 52.36 ± 2.63 HU; root mean squared error were 89.09 ± 6.65 and 108.38 ± 12.23 HU; peak signal‐to‐noise ratio were 29.11 ± 0.60 and 27.65 ± 0.59 dB; and structural similarity index measures were 0.88 ± 0.00 and 0.70 ± 0.01 respectively. No significant differences were identified for DVH metrics accounting the target coverage. Most OARs did not have significant dose deviation, except left lens with 0.70% higher in D‐mean after recalculation (p
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?